Paediatric and neonatal sepsis and inflammation

Pediatr Res. 2022 Jan;91(2):267-269. doi: 10.1038/s41390-021-01918-4. Epub 2022 Jan 19.


Sepsis has a huge impact on global mortality and has been declared as a priority by the World Health organisation the WHO.1 Children have a high incidence of sepsis especially in the neonatal with an estimated 3 million babies affected worldwide and mortality ranges from 11 to 19%.2 In addition, long-term neurodevelopmental outcomes are affected but this is largely unquantified. However, challenges remain in the early recognition, diagnosis and standardised management of sepsis. This series on Sepsis and inflammation in children reviews the conundrums of diagnostic criteria, biomarkers, management and future strategies to improve outcomes.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomarkers / blood
  • Child
  • Humans
  • Infant, Newborn
  • Inflammation / complications*
  • Neonatal Sepsis / blood
  • Neonatal Sepsis / complications*
  • Neonatal Sepsis / therapy


  • Biomarkers